Electrical Muscle Stimulation in the Development of Acquired Weakness in Patients With Severe Sepsis and Septic Shock
NCT ID: NCT03765489
Last Updated: 2018-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2016-11-18
2018-06-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Electrical Stimulation for Preventing Loss of Muscle Mass in Patients With SIRS, Sepsis and Septic Shock
NCT03754257
Neuromuscular Electrical Stimulation for Intensive Care Unit-acquired Weakness Assessment
NCT02706587
Neuromuscular Electrical Stimulation in Critically Ill Patients Aged 80 and Over
NCT07127991
Transcutaneous Electric Muscle Stimulation (TEMS) in Septic Patients
NCT01071343
Neuromuscular Electrical Stimulation and Septic Shock
NCT03193164
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
electrical muscle stimulation
conventional physical therapy according to the adaptation of the "Start to move" protocol of Gosselink et al. plus electrical muscle stimulation: The parameters used in biceps were: 35 Hz, 250 μs and in quadriceps were: 50 Hz, 400 μs. In both, biphasic wave was used, 45 minutes of total work, 5 seconds of contraction and 10 seconds of relaxation and the intensity was adjusted to present a visible contraction
electrical muscle stimulation
electrical muscle stimulation: The parameters used in biceps were: 35 Hz, 250 μs and in quadriceps were: 50 Hz, 400 μs. In both, biphasic wave was used, 45 minutes of total work, 5 seconds of contraction and 10 seconds of relaxation and the intensity was adjusted to present a visible contraction
conventional physical therapy
conventional physical therapy according to the adaptation of the "Start to move" protocol of Gosselink et al
conventional physical therapy
conventional physical therapy according to the adaptation of the "Start to move" protocol of Gosselink et al
conventional physical therapy
conventional physical therapy according to the adaptation of the "Start to move" protocol of Gosselink et al
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
electrical muscle stimulation
electrical muscle stimulation: The parameters used in biceps were: 35 Hz, 250 μs and in quadriceps were: 50 Hz, 400 μs. In both, biphasic wave was used, 45 minutes of total work, 5 seconds of contraction and 10 seconds of relaxation and the intensity was adjusted to present a visible contraction
conventional physical therapy
conventional physical therapy according to the adaptation of the "Start to move" protocol of Gosselink et al
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of severe sepsis or septic shock
* More than 48 hours in VMI
* With sedation and / or neuromuscular blockade
* Autovalent prior to admission to the ICU
Exclusion Criteria
* Multiple trauma
* Previous neuromuscular pathology
* Pacemaker users
* Pregnant women
* BMI\> 35
* Epilepsy
* Those who have refused to sign informed consent
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Chile
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
daniel arellano sepulveda
principal investigator
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OAIC 847/16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.